Genetron Health provides a portfolio of molecular research products designed to support oncology and genomic research. Leveraging Next-Generation Sequencing (NGS) as an advanced technology, enables researchers to explore genetic variations, investigate molecular mechanisms of cancer, and support translational research in precision oncology.
These products are intended for Research Use Only (RUO) and are not intended for use in diagnostic procedures or clinical decision-making.